Biography
Sarah Keohane Williamson
Chief Executive Officer, FCLTGlobal; Board Member, Evercore and EXL
FCLTGlobal is a 501c3 not-for-profit organization whose goal is to rebalance capital markets towards effective long-term capital allocation for sustainable growth.
We work in partnership with over 50 member institutions, who are highly respected global organizations across the investment value chain: asset owners, asset managers, and companies. Together we develop practical tools and resources that encourage longer-term behaviors in business and investment decision-making for economic growth and future savings. We have a team with deep experience in investing, consulting and business based in Boston.
Sarah Keohane Williamson is the Chief Executive Officer of FCLTGlobal. In this role, she leads our efforts at conducting innovative, practical research, engaging with our global membership, sharing our perspectives and research with constituents globally, and building our team.
Williamson assumed her current role in July 2016, after spending over 21 years at Wellington Management in Boston and San Francisco, most recently as a Partner and Director of Alternative Investments. Prior to joining Wellington Management, Williamson spent over five years with McKinsey & Company Inc. in London, Dallas and Boston. She was also a special assistant at the US Department of State and was a mergers & acquisitions investment banker in New York and London for Goldman, Sachs & Co.
In her FCLTGlobal capacity, Williamson is a co-chair of the World Economic Forum Global Future Council on Long-term Investing, a member of the Advisory Board for the Millstein Center for Global Markets and Corporate Ownership at Columbia, and a member of the Hong Kong Institute for Monetary and Financial Research Council of Advisers.
Williamson also serves as a Director of Evercore (NYSE:EVR) and is a member of the Harvard Business School Board of Dean’s Advisors, the Boston Children’s Hospital investment committee and the board of the Whitehead Institute for Biomedical Research.
She earned her MBA, with distinction, from Harvard Business School and her BA in Economics, with honors, from Williams College. She holds the Chartered Financial Analyst and the Chartered Alternative Investment Analyst designations. She is a US citizen and is married with three grown children.
